Colgate-Palmolive Stock Euronext Paris

Equities

COLGA

US1941621039

Personal Products

End-of-day quote Euronext Paris 5-day change 1st Jan Change
- PTS -.--% Intraday chart for Colgate-Palmolive -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 20.23B 0 Sales 2025 * 21.06B 0 Capitalization 77.44B 0
Net income 2024 * 2.89B - Net income 2025 * 3.14B - EV / Sales 2024 * 4.19 x
Net Debt 2024 * 7.3B 0 Net Debt 2025 * 6.81B 0 EV / Sales 2025 * 4 x
P/E ratio 2024 *
26.9 x
P/E ratio 2025 *
24.5 x
Employees -
Yield 2024 *
2.11%
Yield 2025 *
2.22%
Free-Float 55.92%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 59 86-12-31
Director of Finance/CFO 58 20-11-08
Chief Tech/Sci/R&D Officer - 22-08-31
Members of the board TitleAgeSince
Director/Board Member 67 16-03-13
Director/Board Member 67 15-03-10
Director/Board Member 66 05-10-05
More insiders
Colgate-Palmolive Company is one of the worldwide leaders in the manufacturing and marketing of cleaning and hygiene products. The group also products and sells pet food (dogs and cats). Net sales break down by family of products as follows: - hygiene and cleaning products (78%): oral hygiene (toothpaste, toothbrushes, mouthwashes, etc.; Colgate brand), body care (soaps, shower gels, shampoos, conditioners, deodorants, shaving products, etc.; Palmolive, Speed Stick, Softsoap, etc.), household care, and linen care (dishwashing liquids, detergents, stain removers, fabric softeners, bleach, etc.; Palmolive, Ajax, Soupline, Suavitel, etc.). Net sales are distributed geographically as follows: North America (25.9%), Latin America (30.6%), Asia-Pacific (18.3%), Europe (18.1%), Africa and Eurasia (7.1%); - cat and dog foods (22%; Hill's): world leader.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
94.39 USD
Average target price
97.42 USD
Spread / Average Target
+3.20%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW